246 related articles for article (PubMed ID: 23158906)
1. Anti-HBV efficacy of combined siRNAs targeting viral gene and heat shock cognate 70.
Bian Z; Xiao A; Cao M; Liu M; Liu S; Jiao Y; Yan W; Qi Z; Zheng Z
Virol J; 2012 Nov; 9():275. PubMed ID: 23158906
[TBL] [Abstract][Full Text] [Related]
2. [PreC/C gene-targeting RNA interference suppresses hepatitis B virus replication and expression in human hepatoma cells].
Bian ZQ; Liu S; Liu MQ; Xiao A; Jiao Y; Yan WY; Zheng ZX
Zhonghua Yi Xue Za Zhi; 2012 Mar; 92(11):768-72. PubMed ID: 22781359
[TBL] [Abstract][Full Text] [Related]
3. [Transfection of siRNA expressing plasmids targeting S gene inhibits replication and expression of hepatitis B virus in hepatic cancer cells].
Bian ZQ; Cui ZL; Chen WZ; Liu MQ; Yan WY; Zheng ZX
Zhonghua Yi Xue Za Zhi; 2009 Feb; 89(5):347-51. PubMed ID: 19563716
[TBL] [Abstract][Full Text] [Related]
4. siRNA pool targeting different sites of human hepatitis B surface antigen efficiently inhibits HBV infection.
Chen Y; Mahato RI
J Drug Target; 2008 Feb; 16(2):140-8. PubMed ID: 18274934
[TBL] [Abstract][Full Text] [Related]
5. In vitro activity of cepharanthine hydrochloride against clinical wild-type and lamivudine-resistant hepatitis B virus isolates.
Zhou YB; Wang YF; Zhang Y; Zheng LY; Yang XA; Wang N; Jiang JH; Ma F; Yin DT; Sun CY; Wang QD
Eur J Pharmacol; 2012 May; 683(1-3):10-5. PubMed ID: 22387093
[TBL] [Abstract][Full Text] [Related]
6. 5'-triphosphate-siRNA activates RIG-I-dependent type I interferon production and enhances inhibition of hepatitis B virus replication in HepG2.2.15 cells.
Chen X; Qian Y; Yan F; Tu J; Yang X; Xing Y; Chen Z
Eur J Pharmacol; 2013 Dec; 721(1-3):86-95. PubMed ID: 24099962
[TBL] [Abstract][Full Text] [Related]
7. 5' Triphosphorylated small interfering RNAs control replication of hepatitis B virus and induce an interferon response in human liver cells and mice.
Ebert G; Poeck H; Lucifora J; Baschuk N; Esser K; Esposito I; Hartmann G; Protzer U
Gastroenterology; 2011 Aug; 141(2):696-706, 706.e1-3. PubMed ID: 21684282
[TBL] [Abstract][Full Text] [Related]
8. Heat stress cognate 70 host protein as a potential drug target against drug resistance in hepatitis B virus.
Wang YP; Liu F; He HW; Han YX; Peng ZG; Li BW; You XF; Song DQ; Li ZR; Yu LY; Cen S; Hong B; Sun CH; Zhao LX; Kreiswirth B; Perlin D; Shao RG; Jiang JD
Antimicrob Agents Chemother; 2010 May; 54(5):2070-7. PubMed ID: 20176893
[TBL] [Abstract][Full Text] [Related]
9. RNA interference inhibits hepatitis B virus gene expression and replication in HepG2-N10 cells.
Ren JL; Pan JS; Cheng T; Dong J; Lu YP; Huang SJ; Shi HX; Wang L; Lian YM
Chin J Dig Dis; 2006; 7(4):230-6. PubMed ID: 17054586
[TBL] [Abstract][Full Text] [Related]
10. [Inhibition of hepatitis B virus replication and expression by RNA interference in vitro].
Zhu C; Fan XG; Li N; Ying RS; Tian XF
Zhonghua Yi Xue Za Zhi; 2005 Sep; 85(35):2503-6. PubMed ID: 16321280
[TBL] [Abstract][Full Text] [Related]
11. Immunostimulatory siRNA with a uridine bulge leads to potent inhibition of HBV and activation of innate immunity.
Lan T; Wei Z; He Y; Wan S; Liu L; Cheng B; Li R; Chen H; Liu G; Meng Z
Virol J; 2021 Feb; 18(1):37. PubMed ID: 33602251
[TBL] [Abstract][Full Text] [Related]
12. Effective inhibition of hepatitis B virus replication by small interfering RNAs expressed from human foamy virus vectors.
Sun Y; Li Z; Li L; Li J; Liu X; Li W
Int J Mol Med; 2007 Apr; 19(4):705-11. PubMed ID: 17334648
[TBL] [Abstract][Full Text] [Related]
13. Combination therapy of siRNAs mediates greater suppression on hepatitis B virus cccDNA in HepG2.2.15 cell.
Xin XM; Li GQ; Guan XR; Li D; Xu WZ; Jin YY; Gu HX
Hepatogastroenterology; 2008; 55(88):2178-83. PubMed ID: 19260501
[TBL] [Abstract][Full Text] [Related]
14. Combination of small interfering RNAs mediates greater inhibition of human hepatitis B virus replication and antigen expression.
Chen Z; Xu ZF; Ye JJ; Yao HP; Zheng S; Ding JY
J Zhejiang Univ Sci B; 2005 Apr; 6(4):236-41. PubMed ID: 15754419
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of hepatitis B virus replication by shRNAs in stably HBV expressed HEPG2 2.2.15 cell lines.
Kayhan H; Karatayli E; Turkyilmaz AR; Sahin F; Yurdaydin C; Bozdayi AM
Arch Virol; 2007; 152(5):871-9. PubMed ID: 17245534
[TBL] [Abstract][Full Text] [Related]
16. [Effect of PLSCR1 on the Antiviral Activity of IFN against HBV in HepG2 Cells].
Li Q; Zhang B; Zhang Q; Wang X; Huo Y; Yang J
Bing Du Xue Bao; 2016 Nov; 32(6):747-51. PubMed ID: 30004207
[TBL] [Abstract][Full Text] [Related]
17. [Inhibition of HBV replication and antigen expression by RNA interference against different targets].
Zhang BQ; Huang Y; Tang N; Wu Y; Zhang J; Chen WX; He TC; Huang AL
Zhonghua Gan Zang Bing Za Zhi; 2006 Sep; 14(9):662-5. PubMed ID: 16995979
[TBL] [Abstract][Full Text] [Related]
18. Long-term suppression of hepatitis B virus replication by short hairpin RNA expression using the scaffold/matrix attachment region-based replicating vector system pEPI-1.
Jenke AC; Wilhelm AD; Orth V; Lipps HJ; Protzer U; Wirth S
Antimicrob Agents Chemother; 2008 Jul; 52(7):2355-9. PubMed ID: 18474581
[TBL] [Abstract][Full Text] [Related]
19. Doubly Spliced RNA of Hepatitis B Virus Suppresses Viral Transcription via TATA-Binding Protein and Induces Stress Granule Assembly.
Tsai KN; Chong CL; Chou YC; Huang CC; Wang YL; Wang SW; Chen ML; Chen CH; Chang C
J Virol; 2015 Nov; 89(22):11406-19. PubMed ID: 26339052
[TBL] [Abstract][Full Text] [Related]
20. Interferon-inducible MX2 is a host restriction factor of hepatitis B virus replication.
Wang YX; Niklasch M; Liu T; Wang Y; Shi B; Yuan W; Baumert TF; Yuan Z; Tong S; Nassal M; Wen YM
J Hepatol; 2020 May; 72(5):865-876. PubMed ID: 31863794
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
